Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Integrating AI, Machine Learning, and Animal Models for Precision Oncology: Bridging Preclinical and Clinical Gaps
0
Zitationen
4
Autoren
2025
Jahr
Abstract
The limited translatability of animal models can be significantly amplified by integration of Artificial Intelligence (AI) and Machine Learning (ML). This Viewpoint represents a fresh paradigm in pharmacology and translational science, one that accelerates hypothesis testing, reduces resource burden, and improves clinical predictability. By aligning computational precision with experimental rigor, this integrated approach provides more ethical, scalable, and personalized cancer therapeutics.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.850 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.540 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.752 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.106 Zit.